Insider · CIK 0001691868
Berkenblit Anna
Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA
Transactions
32
Companies
2
Filings
17
CIK
0001691868
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-13 | SRZNSurrozen, Inc./DE · Director Stock Option (right to buy)A Award | — |
| 2025-05-14 | SRZNSurrozen, Inc./DE · Option (right to buy)A Award | — |
| 2024-06-05 | SRZNSurrozen, Inc./DE · Option (right to buy)A Award | — |
| 2023-06-30 | ImmunoGen, Inc.A Award | +$13.2K |
| 2023-05-18 | SRZNSurrozen, Inc./DE · Option (right to buy)A Award | — |
| 2023-02-03 | ImmunoGen, Inc.Restricted Stock UnitA Award | — |
| 2023-02-03 | ImmunoGen, Inc.Stock Option (right to buy)A Award | — |
| 2023-02-03 | ImmunoGen, Inc.Restricted Stock UnitA Award | — |
| 2022-12-30 | ImmunoGen, Inc.A Award | +$1,709.12 |
| 2022-11-14 | ImmunoGen, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-06-30 | ImmunoGen, Inc.A Award | +$11.8K |
| 2022-06-07 | SRZNSurrozen, Inc./DE · Option (right to buy)A Award | — |
| 2022-05-20 | ImmunoGen, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-02-04 | ImmunoGen, Inc.Stock Option (right to buy)A Award | +$1.66M |
| 2021-12-31 | ImmunoGen, Inc.A Award | +$9,861.6 |
| 2021-06-30 | ImmunoGen, Inc.A Award | +$11.4K |
| 2021-02-05 | ImmunoGen, Inc.Common Stock (right to buy)A Award | +$2.17M |
| 2020-12-31 | ImmunoGen, Inc.A Award | +$8,900.12 |
| 2020-06-30 | ImmunoGen, Inc.A Award | +$11.9K |
| 2020-02-24 | ImmunoGen, Inc.S Sale | −$129K |
| 2020-02-07 | ImmunoGen, Inc.Stock Option (right to buy)A Award | +$1.35M |
| 2019-07-01 | ImmunoGen, Inc.A Award | +$9,623.2 |
| 2019-01-31 | ImmunoGen, Inc.Stock Option (right to buy)A Award | +$1.34M |
| 2019-01-31 | ImmunoGen, Inc.Stock Option (right to buy)A Award | +$486K |
| 2019-01-03 | ImmunoGen, Inc.A Award | +$10K |
| 2018-10-16 | ImmunoGen, Inc.S Sale | −$46.8K |
| 2018-09-10 | ImmunoGen, Inc.S Sale | −$55.4K |
| 2018-02-22 | ImmunoGen, Inc.S Sale | −$92.7K |
| 2018-02-21 | ImmunoGen, Inc.S Sale | −$189K |
| 2018-02-15 | ImmunoGen, Inc.Stock Option (right to buy)A Award | +$1.86M |
| 2017-09-13 | ImmunoGen, Inc.S Sale | −$10.5K |
| 2017-02-21 | ImmunoGen, Inc.A Award | +$389K |
Recent filings
- 4Berkenblit Anna0001193125-26-224117SEC(opens sec.gov)
- 4Berkenblit Anna0001593968-25-000607SEC(opens sec.gov)
- 4Berkenblit Anna0001593968-24-000826SEC(opens sec.gov)
- 4Berkenblit Anna0001415889-23-010828SEC(opens sec.gov)
- 4Berkenblit Anna0000950170-23-023326SEC(opens sec.gov)
- 4Berkenblit Anna0001415889-23-002106SEC(opens sec.gov)
- 4Berkenblit Anna0001415889-23-000108SEC(opens sec.gov)
- 4Berkenblit Anna0001415889-22-012990SEC(opens sec.gov)
- 4Berkenblit Anna0001415889-22-007332SEC(opens sec.gov)
- 4Berkenblit Anna0001593968-22-001108SEC(opens sec.gov)
- 4Berkenblit Anna0001179110-22-000927SEC(opens sec.gov)
- 4Berkenblit Anna0001179110-22-000106SEC(opens sec.gov)
- 4Berkenblit Anna0001179110-21-007318SEC(opens sec.gov)
- 4Berkenblit Anna0001179110-21-001492SEC(opens sec.gov)
- 4Berkenblit Anna0001179110-21-000081SEC(opens sec.gov)
- 4Berkenblit Anna0001179110-20-007818SEC(opens sec.gov)
- 4Berkenblit Anna0001179110-20-002185SEC(opens sec.gov)
Companies
Address
C/O SURROZEN, INC. 171 OYSTER POINT BLVD., SUITE 400
SOUTH SAN FRANCISCO, CA, 94080